Literature DB >> 30634017

RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells.

Xiao-Ling Zhang1, Zhen-Zhen Wang1, Qian-Hang Shao1, Zhao Zhang1, Lin Li2, Zhen-Yu Guo3, Hong-Mei Sun3, Yi Zhang4, Nai-Hong Chen5.   

Abstract

Deletions or some mutations in the gene encoding the multifunctional protein, DJ-1, have been considered to be linked with autosomal recessive early onset Parkinson's disease (PD). Current emerging evidence suggests that DJ-1 is involved in the protection against oxidative stress-induced mitochondrial damage. However, the exact molecular mechanisms underlying this are not completely clear. The aim of this study was to investigate the effects of DJ-1 on the Akt pathway, nuclear factor erythroid 2-related factor (Nrf2), and c-Jun N-terminal kinase (JNK) with regard to modulating mitochondrial function. Here we showed that knockdown of DJ-1 resulted in mitochondrial dysfunction, including a decrease in active mitochondrial mass, complex I deficits, and inhibition of cellular adenosine 5'-triphosphate (ATP) content in the dopaminergic neuron-like cells PC12 and SH-SY5Y. Additionally, loss of DJ-1 impaired Akt signaling, and reduced nuclear translocation of Nrf2, thereby inhibiting activity of Nrf2-regulated downstream antioxidant enzymes such as heme oxygenase-1 and NAD(P)H quinone oxidoreductase 1. Moreover, DJ-1 knockdown also led to a significant increase in the mitochondrial reactive oxygen species, and then promoted the activation of JNK pathways. Furthermore, oxidative stress and mitochondrial dysfunction induced by knockdown of DJ-1 were blocked by a JNK inhibitor, which confirmed the important role of JNK activation in mitochondrial dysfunction. In conclusion, the present study indicates that DJ-1 knockdown leads to mitochondrial dysfunction in dopaminergic neuron-like cells, at least in part, through suppressing the Akt/GSK3β pathway and impairing the oxidative stress response, as well as through the subsequent increased JNK activation in dopaminergic neuron-like cells.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; DJ-1; Mitochondrial dysfunction; Nuclear factor erythroid 2 (Nrf2); c-Jun N-terminal kinase (JNK)

Mesh:

Substances:

Year:  2019        PMID: 30634017     DOI: 10.1016/j.brainresbull.2019.01.007

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Inhibition of mitochondrial and cytosolic calpain attenuates atrophy in myotubes co-cultured with colon carcinoma cells.

Authors:  Xianliang Zeng; Li Zhao; Sizeng Chen; Xiantao Li
Journal:  Oncol Lett       Date:  2020-12-17       Impact factor: 2.967

2.  Protective effect of mesenchymal stem cell-derived exosomal treatment of hippocampal neurons against oxygen-glucose deprivation/reperfusion-induced injury.

Authors:  Xiao-Fang Guo; Shuang-Shuang Gu; Jun Wang; Hao Sun; Yu-Juan Zhang; Peng-Fei Yu; Jin-Song Zhang; Lei Jiang
Journal:  World J Emerg Med       Date:  2022

Review 3.  Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson's Disease.

Authors:  Xiao-Le Wang; Si-Tong Feng; Ya-Ting Wang; Yu-He Yuan; Zhi-Peng Li; Nai-Hong Chen; Zhen-Zhen Wang; Yi Zhang
Journal:  Cell Mol Neurobiol       Date:  2021-02-02       Impact factor: 5.046

4.  Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension.

Authors:  Yong-Jie Chen; Yi Li; Xian Guo; Bo Huo; Yue Chen; Yi He; Rui Xiao; Xue-Hai Zhu; Ding-Sheng Jiang; Xiang Wei
Journal:  Front Pharmacol       Date:  2021-12-01       Impact factor: 5.810

Review 5.  Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases.

Authors:  Xiaoxian Xie; Ruonan Shu; Chunan Yu; Zhengwei Fu; Zezhi Li
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

6.  A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson's Disease Treatment.

Authors:  Francisco José Sanz; Cristina Solana-Manrique; Josema Torres; Esther Masiá; María J Vicent; Nuria Paricio
Journal:  Neurotherapeutics       Date:  2021-10-25       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.